BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility – A proteomics study-Reference-Cited by-同舟云学术

BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility – A proteomics study

Published:2015-06-17 Issue:12 Volume:14 Page:1884-1892
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Gau David M¹,Lesnock Jamie L²,Hood Brian L³,Bhargava Rohit⁴,Sun Mai⁵,Darcy Kathleen³,Luthra Soumya⁶,Chandran Uma⁶,Conrads Thomas P³,Edwards Robert P⁷,Kelley Joseph L⁷,Krivak Thomas C⁸,Roy Partha¹⁹¹⁰

Affiliation:

1. Department of Bioengineering; University of Pittsburgh; Pittsburgh, PA, USA

2. Mid Atlantic Gynecologic Oncology of Mon General Hospital; Morgantown, WV, USA

3. Womens Health Integrated Research Center at Inova Health System; Gynecologic Cancer Center of Excellence; Henry Jackson Foundation for the Advancement of Military Medicine; Annandale, VA, USA

4. Department of Pathology; Magee Womens Hospital of UPMC; Pittsburgh, PA, USA

5. Genomics and Proteomics Core facility; University of Pittsburgh; Pittsburgh, PA, USA

6. Department of Biomedical Informatics; University of Pittsburgh; Pittsburgh, PA, USA

7. Division of Gynecologic Oncology; Magee Womens Hospital of UPMC; Pittsburgh, PA, USA

8. West Penn Allegheny Health System; Pittsburgh, PA, USA

9. Magee Womens Research Institute; Magee Womens Hospital of UPMC;Pittsburgh, PA, USA

10. Department of Pathology; University of Pittsburgh; Pittsburgh, PA, USA

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1036203

Reference56 articles.

1. Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer

2. BRCA1andBRCA2mutations account for a large proportion of ovarian carcinoma cases

3. Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

4. “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinical prognostic model related to T cells based on machine learning for predicting the prognosis and immune response of ovarian cancer;Heliyon;2024-09

2. Identification and validation of a novel defined stress granule-related gene signature for predicting the prognosis of ovarian cancer via bioinformatics analysis;2024-05-07

3. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer;Scientific Reports;2024-04-29

4. Deficiency in DNA Damage Repair Proteins Promotes Prostate Cancer Cell Migration through Oxidative Stress;Onco;2024-03-28

5. SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma;International Journal of Molecular Sciences;2023-11-29